Organization

Field Name

ID

Required

KCR

Grade Post Therapy Clin (yc)

30141

yes 

SEER

Grade Post Therapy Clin (yc)

1068

yes 

Note 1 Leave Grade Post Therapy Clin (yc) blank when

  • No neoadjuvant therapy
  • Clinical or pathological case only
  • Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
  • There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological

Note 2 Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.

Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.

Note 4 The grading system for this chapter is based on histology

  • Immature teratomas and serous carcinomas Use codes L, H, or 9. This include the following ICD-O-3 codes 8441/2, 8441/3, 8460/3, 8461/3, 8474/3, 9080/3
  • All other histologies Code 1-3 if a nuclear grade is documented, otherwise code 9
  • If your registry collects ovarian borderline tumors (/1), code “B” for grade

Note 5 G3 includes anaplastic.

Note 6 Code 9 (unknown) when

  • Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
  • Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
  • Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available

Code

Description

1

G1: Well differentiated

2

G2: Moderately differentiated

3

G3: Poorly differentiated, undifferentiated

B

GB: Borderline Tumor

L

Low grade

H

High grade

9

Grade cannot be assessed (GX); Unknown

<BLANK>

See Note 1